High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1

NCT00735969 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

NIH

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Peginterferon
DRUG: Ribavirin

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)